Alpha Centric Advisors LLC Oyster Point Pharma, Inc. Transaction History

Alpha Centric Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 25, 2022	SELL	$10.17 - $18.96 $1 Million - $1.87 Million	-98,500 Closed	0 $0
Q3 2021 Mar 09, 2022	BUY	$11.67 - $18.07 $723,540 - $1.12 Million	62,000 Added 169.86%	98,500 $1.17 Million
Q2 2021 Mar 09, 2022	BUY	$16.25 - $21.51 $235,625 - $311,895	14,500 Added 65.91%	36,500 $627,000
Q1 2021 Mar 09, 2022	BUY	$17.92 - $25.86 $179,200 - $258,600	10,000 Added 83.33%	22,000 $402,000
Q4 2020 Mar 11, 2022	BUY	$18.13 - $25.18 $217,560 - $302,160	12,000 New	12,000 $226,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Centric Advisors LLC with notifications on news.